Pure Global

WBC LYSE - India CDSCO Medical Device Registration

WBC LYSE is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000075_89b71ada39e1430b35f3f975ee4ab51f_71917b54223f56d5ef5eec0cc23b49c3. This device is marketed under the brand name WBC Reagent, PART B. The license holder is Abbott Healthcare Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
WBC LYSE
UID: IMP/IVD/2022/000075_89b71ada39e1430b35f3f975ee4ab51f_71917b54223f56d5ef5eec0cc23b49c3

Brand Name

WBC Reagent, PART B

Device Class

Class B

Approving Authority

CDSCO

Product Information

Act as the diluent for the WBC. Osmotically lyse the red cells. Act as a diluent for Reticulocytes

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing